374 related articles for article (PubMed ID: 11588543)
21. Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta-analysis.
Zhang Y; Gao X; He Z; Jia H; Chen M; Wang X; Hong L; Cui Y; Wan J
Liver Int; 2022 Aug; 42(8):1814-1822. PubMed ID: 35689520
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease.
Lunder AK; Hov JR; Borthne A; Gleditsch J; Johannesen G; Tveit K; Viktil E; Henriksen M; Hovde Ø; Huppertz-Hauss G; Høie O; Høivik ML; Monstad I; Solberg IC; Jahnsen J; Karlsen TH; Moum B; Vatn M; Negård A
Gastroenterology; 2016 Oct; 151(4):660-669.e4. PubMed ID: 27342213
[TBL] [Abstract][Full Text] [Related]
23. Clinical profile and outcome of primary sclerosing cholangitis: A single-centre experience from western India.
Tibdewal P; Bhatt P; Jain A; Gupta D; Bhatia S; Shukla A
Indian J Gastroenterol; 2019 Aug; 38(4):295-302. PubMed ID: 31515764
[TBL] [Abstract][Full Text] [Related]
24. [Clinicobiological and morphological profiles of primary sclerosing cholangitis in Tunisia].
Héla K; Asma OK; Ali A; Nadia BM; Mohamed MA; Nabil T; Abdeljabbar G; Béchir Z; Nabyl BM
Tunis Med; 2014 May; 92(5):323-8. PubMed ID: 25504385
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for primary sclerosing cholangitis.
Boonstra K; de Vries EM; van Geloven N; van Erpecum KJ; Spanier M; Poen AC; van Nieuwkerk CM; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; Beuers U; Ponsioen CY;
Liver Int; 2016 Jan; 36(1):84-91. PubMed ID: 26077553
[TBL] [Abstract][Full Text] [Related]
26. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
Zheng HH; Jiang XL
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
[TBL] [Abstract][Full Text] [Related]
27. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease.
Bosch DE; Yeh MM
Hum Pathol; 2017 Nov; 69():55-62. PubMed ID: 28970141
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
Azzam N; AlRuthia Y; Alharbi O; Aljebreen A; Almadi M; Loftus EV
Hepatol Int; 2020 Dec; 14(6):1114-1124. PubMed ID: 33369708
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.
Lascurain L; Jensen MK; Guthery SL; Holmen J; Deneau M
Inflamm Bowel Dis; 2016 Jan; 22(1):146-50. PubMed ID: 26619054
[TBL] [Abstract][Full Text] [Related]
30. Risk factors and clinical courses of concomitant primary sclerosing cholangitis and ulcerative colitis: a Korean multicenter study.
Park YE; Cheon JH; Park JJ; Kim YJ; Choi CH; Park Y; Park SJ; Kim TI; Kim WH
Int J Colorectal Dis; 2018 Oct; 33(10):1497-1500. PubMed ID: 29987360
[TBL] [Abstract][Full Text] [Related]
31. Clinical course of primary sclerosing cholangitis and concomitant ulcerative colitis - a preliminary report of retrospective study among patients from Southern Poland.
Głowacki MK; Zwolińska-Wcisło M; Frączek P; Gomulska M; Owczarek D; Cibor D; Cieśla A; Mach T
Folia Med Cracov; 2015; 55(2):61-8. PubMed ID: 26839244
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the Clinical Course of Primary Sclerosing Cholangitis in Paediatric Population-Single Center Study.
Wiecek S; Wojtyniak A; Pindur B; Machnikowska-Sokołowska M; Gruszczyńska K; Grzybowska-Chlebowczyk U
Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34199130
[No Abstract] [Full Text] [Related]
33. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.
Jiang L; Xia B; Li J; Ye M; Yan W; Deng C; Ding Y; Luo H; Hou W; Zhao Q; Liu N; Ren H; Hou X; Xu H
Inflamm Bowel Dis; 2006 Mar; 12(3):212-7. PubMed ID: 16534423
[TBL] [Abstract][Full Text] [Related]
34. Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease.
Wang MH; Friton JJ; Raffals LE; Leighton JA; Pasha SF; Picco MF; Monroe K; Nix BD; Newberry RD; Faubion WA
BMJ Open Gastroenterol; 2023 Oct; 10(1):. PubMed ID: 37832963
[TBL] [Abstract][Full Text] [Related]
35. Relationship of inflammatory bowel disease and primary sclerosing cholangitis.
Fausa O; Schrumpf E; Elgjo K
Semin Liver Dis; 1991 Feb; 11(1):31-9. PubMed ID: 2047887
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life among patients with primary sclerosing cholangitis.
Haapamäki J; Tenca A; Sintonen H; Barner-Rasmussen N; Färkkilä MA
Liver Int; 2015 Sep; 35(9):2194-201. PubMed ID: 25546575
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
[TBL] [Abstract][Full Text] [Related]
38. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
Guerra I; Bujanda L; Castro J; Merino O; Tosca J; Camps B; Gutiérrez A; Gordillo Ábalos J; de Castro L; Iborra M; Carbajo AY; Taxonera C; Rodríguez-Lago I; Mesonero F; de Francisco R; Gómez-Gómez GJ; Chaparro M; Tardillo CA; Rivero M; Algaba A; Martín Arranz E; Cañete F; Vicente R; Sicilia B; Antolín B; Prieto V; Márquez L; Benítez JM; Camo P; Piqueras M; Gargallo CJ; Hinojosa E; Huguet JM; Pérez Calle JL; Van Domselaar M; Rodriguez C; Calvet X; Muñoz-Villafranca C; García-Sepulcre MF; Munoz-Garrido P; Fernández-Clotet A; Gómez Irwin L; Hernández S; Guardiola J; Sempere L; González Muñoza C; Hernández V; Beltrán B; Barrio J; Alba C; Moraleja I; López-Sanromán A; Riestra S; Martínez Montiel P; Garre A; Arranz L; García MJ; Martín Arranz MD; Corsino P; Arias L; Fernández-Salazar L; Fernández-Pordomingo A; Andreu M; Iglesias E; Ber Y; Mena R; Arroyo Villarino MT; Mora M; Ruiz L; López-Serrano P; Blazquez I; Villoria A; Fernández M; Bermejo F; Banales JM; Domènech E; Gisbert JP;
J Crohns Colitis; 2019 Dec; 13(12):1492-1500. PubMed ID: 31063540
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?
Nakazawa T; Naitoh I; Hayashi K; Sano H; Miyabe K; Shimizu S; Joh T
World J Gastroenterol; 2014 Mar; 20(12):3245-54. PubMed ID: 24696608
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis.
Ngu JH; Gearry RB; Wright AJ; Stedman CA
Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1092-7; quiz e135. PubMed ID: 21893134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
